Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell Cancer

Title
Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell Cancer
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOTHERAPY
Volume 31, Issue 6, Pages 569-576
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2009-03-06
DOI
10.1097/cji.0b013e318177a4ba

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started